Akèy › Maladi dejeneratif nè › Massachusetts
Etid klinik pou Maladi dejeneratif nè nan Massachusetts
6 etid pou Maladi dejeneratif nè ap chèche patisipan nan sit nan Massachusetts.
Vil nan Massachusetts
Tèks ofisyèl etid la (Anglè)
An Open-Label Exploratory Study of Fosigotifator in Participants With Vanishing White Matter Disease
- Massachusetts General Hospital /ID# 270960, Boston
Ap rekriteFaz 1/2
6 Months · Tout sèks · Mizajou Sep 24, 2026 · NCT05757141A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
- Massachusetts General Hospital - Charlestown, Charlestown
- K2 Medical Research - Foxborough, Foxborough
- Neurology Center of New England, Foxborough
- ak 1 plis
Ap rekriteFaz 2
Laj 55 a 85 · Tout sèks · Mizajou Sep 22, 2026 · NCT07589595A First-In-Human Study of LY3954068 in Participants With Early Symptomatic Alzheimer's Disease
- Massachusetts General Hospital (MGH), Charlestown
Ap rekriteFaz 1
Laj 50 a 85 · Tout sèks · Mizajou Aug 24, 2026 · NCT06297590PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort
- Boston University, Boston
- Massachusetts General Hospital, Boston
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 30 ak plis · Tout sèks · Mizajou Jul 27, 2026 · NCT04477785Hereditary Spastic Paraplegia Genomic Sequencing Initiative (HSPseq)
- Boston Children's Hospital, Boston
Ap rekriteEtid obsèvasyon
1 Month – 30 Years · Tout sèks · Mizajou Mar 18, 2026 · NCT05354622Passive Sensor Identification of Digital Biomarkers to Assess Effects of Orally Administered Nicotinamide Riboside
- McLean Hospital, Belmont
Ap rekriteEtid obsèvasyon
Laj 18 a 89 · Tout sèks · Mizajou Nov 6, 2025 · NCT05245903Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.